Medication-Assisted Treatment
Praxis is no longer offering this training. To fulfill this BSAS required training, please contact OBAT TTA.
Access to medication-assisted treatment can mean the difference between life and death. Research shows that medication-assisted treatment (MAT) is effective in reducing relapse when used in combination with other psycho-social treatment and recovery support strategies.
Neonatal Abstinence Syndrome: Webinars for Health Professionals
To address the specific needs of women who are pregnant and on MAT, Praxis developed a webcast series for health professionals. Click on the links below to watch the videos:
- Supports for Family Safety, Development, and Well-Being
- MAT and Pregnancy: Hospital-Based Management of Pregnant Women with Opioid Use Disorders
- MAT in Pregnancy: An Introduction
- Managing Neonatal Abstinence Syndrome
- MAT and Pregnancy: Dosing and Regulatory Issues
- MAT and Pregnancy: The Evidence on Tapering
Praxis Resources
Massachusetts Resources
Educational Resources
- Buprenorphine (Suboxone), but not naltrexone or its extended release version Vivitrol, is associated with reduced overdose risk
- TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Addiction Programs (SAMHSA)
- Video: Addiction: HBO Video about Medication-Assisted Treatment
- Q&A: Opioid Agonist Therapy: The Duration Dilemma (American Psychiatric Association)